Classical conditioning of antidepressant placebo effects in mice

被引:8
作者
Krimmel, Samuel R. [1 ,2 ,3 ]
Zanos, Panos [1 ]
Georgiou, Polymnia [1 ]
Colloca, Luana [1 ,4 ,5 ,6 ]
Gould, Todd D. [1 ,7 ,8 ,9 ]
机构
[1] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Nursing, Dept Pain Translat Symptom Sci, Baltimore, MD 21201 USA
[5] Univ Maryland, Dept Anesthesiol, Sch Med, Baltimore, MD 21201 USA
[6] Univ Maryland, Ctr Adv Chron Pain Res, Baltimore, MD 21201 USA
[7] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA
[8] Univ Maryland, Dept Anat & Neurobiol, Sch Med, Baltimore, MD 21201 USA
[9] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA
关键词
Ketamine; Placebo; Antidepressant; Classical conditioning; Depression; Animal model; Mice; Biological sex; SEX-DIFFERENCES; DOUBLE-BLIND; KETAMINE; ANALGESIA; MECHANISMS; ANTAGONIST; DEPRESSION; RECEPTOR; EXPECTANCIES; EXPECTATION;
D O I
10.1007/s00213-019-05347-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction Placebo effects in human clinical trials for depression treatment are robust and often comparable to drug effects. Placebo effects are traditionally difficult to study in rodents due to the slow-onset action of classical antidepressant drugs. We hypothesized that the rapid antidepressant actions of ketamine would allow modeling antidepressant placebo effects in rodents. Methods Male and female CD-1 mice received either ketamine or saline injections with concomitant exposure to specific environmental conditioning stimuli, for a total of three drug/conditioning sessions each 2 weeks apart. Two weeks later, during an evocation phase, mice were exposed to the drug-paired conditioning stimuli or no conditioned stimuli followed by testing for motor stimulatory actions and antidepressant-like effects using the forced swim test. Negative (no ketamine administration at any time) and positive (acute ketamine administration prior to evocation testing) control groups were included as comparators. Results Both male and female mice exhibited increased locomotor activity following ketamine administration during the conditioning phase, which was not observed following exposure to the conditioning stimuli. Exposure to the conditioning stimuli previously paired with ketamine, similar to an acute ketamine administration, reduced immobility time in the forced swim test both 1 and 24 h after administration in male, but not female, mice. Conclusions These results represent the first evidence of antidepressant-like placebo-conditioned effects in an animal model. The developed approach can be used as a model to explore the neurobiological mechanisms of placebo effects, their possible sexually dimorphic effects, and relevance to mechanisms underlying antidepressant action.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 60 条
  • [11] Interaction between expectancies and drug effects: an experimental investigation of placebo analgesia with caffeine as an active placebo
    Bjorkedal, Espen
    Flaten, Magne Arve
    [J]. PSYCHOPHARMACOLOGY, 2011, 215 (03) : 537 - 548
  • [12] Sex differences in the antidepressant-like effects of ketamine
    Carrier, Nicole
    Kabbaj, Mohamed
    [J]. NEUROPHARMACOLOGY, 2013, 70 : 27 - 34
  • [13] THE PLACEBO EFFECT: FROM CONCEPTS TO GENES
    Colagiuri, B.
    Schenk, L. A.
    Kessler, M. D.
    Dorsey, S. G.
    Colloca, L.
    [J]. NEUROSCIENCE, 2015, 307 : 171 - 190
  • [14] The Placebo Effect in Pain Therapies
    Colloca, Luana
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59, 2019, 59 : 191 - 211
  • [15] Relieving pain using dose-extending placebos: a scoping review
    Colloca, Luana
    Enck, Paul
    DeGrazia, David
    [J]. PAIN, 2016, 157 (08) : 1590 - 1598
  • [16] Vasopressin Boosts Placebo Analgesic Effects in Women: A Randomized Trial
    Colloca, Luana
    Pine, Daniel S.
    Ernst, Monique
    Miller, Franklin G.
    Grillon, Christian
    [J]. BIOLOGICAL PSYCHIATRY, 2016, 79 (10) : 794 - 802
  • [17] Placebo analgesia: Psychological and neurobiological mechanisms
    Colloca, Luana
    Klinger, Regine
    Flor, Herta
    Bingel, Ulrike
    [J]. PAIN, 2013, 154 (04) : 511 - 514
  • [18] Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
    Fava, Maurizio
    Freeman, Marlene P.
    Flynn, Martina
    Judge, Heidi
    Hoeppner, Bettina B.
    Cusin, Cristina
    Ionescu, Dawn F.
    Mathew, Sanjay J.
    Chang, Lee C.
    Iosifescu, Dan V.
    Murrough, James
    Debattista, Charles
    Schatzberg, Alan F.
    Trivedi, Madhukar H.
    Jha, Manish K.
    Sanacora, Gerard
    Wilkinson, Samuel T.
    Papakostas, George I.
    [J]. MOLECULAR PSYCHIATRY, 2020, 25 (07) : 1592 - 1603
  • [19] Ketamine administration in depressive disorders: a systematic review and meta-analysis
    Fond, Guillaume
    Loundou, Anderson
    Rabu, Corentin
    Macgregor, Alexandra
    Lancon, Christophe
    Brittner, Marie
    Micoulaud-Franchi, Jean-Arthur
    Richieri, Raphaelle
    Courtet, Philippe
    Abbar, Mocrane
    Roger, Matthieu
    Leboyer, Marion
    Boyer, Laurent
    [J]. PSYCHOPHARMACOLOGY, 2014, 231 (18) : 3663 - 3676
  • [20] Review: benefits of antidepressants over placebo limited except in very severe depression
    Fournier, Jay
    Kirsch, Irving
    [J]. EVIDENCE-BASED MENTAL HEALTH, 2010, 13 (02) : 49 - 49